Latest News for: mhra
Edit
MHRA data requirements to support regulatory decision making (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 02 Jul 2026
MHRA - Medicines and Healthcare products Regulatory Agency published this content on ...
Edit
Making regulation a catalyst, not a barrier, for UK life sciences (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 02 Jul 2026
Edit
MHRA authorises gemcitabine delivery system for adults with BCG-unresponsive high-risk non-muscle invasive bladder cancer (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 01 Jul 2026
Julian Beach, MHRA Interim Executive Director of Healthcare Quality and Access, said. ... As with any medicine, the MHRA will keep the safety and effectiveness of this system under close review ... The MHRA ...
Edit
MHRA secures convictions after a decade-long investigation into falsely marked baby-feeding devices (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 01 Jul 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has today secured convictions following a long running investigation led by its Devices Compliance Unit into the illegal supply of medical devices used in hospitals across the UK.
Edit
MHRA authorises gemcitabine delivery system for adults with BCG-unresponsive high-risk non-muscle invasive bladder cancer (FSA - Food Standards Agency)
Public Technologies 01 Jul 2026
Julian Beach, MHRA Interim Executive Director of Healthcare Quality and Access, said. ... As with any medicine, the MHRA will keep the safety and effectiveness of this system under close review ... The MHRA ...
Edit
MHRA secures convictions after a decade-long investigation into falsely marked baby-feeding devices (FSA - Food Standards Agency)
Public Technologies 01 Jul 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has secured convictions following a long running investigation led by its Devices Compliance Unit into the illegal supply of medical devices used in hospitals across the UK.
Edit
Hastings Tribune
25 Jun 2026
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™
Approval of pediatric strategy validates clinical data package and accelerates the regulatory path for CORDStrom™ in the United Kingdom ... .
Edit
Evidence Review of FDA, MAUDE, MHRA and EU Records Finds Independent Ultrasound Servicing Safe, Cheaper and Essential
PR Newswire 25 Jun 2026
Edit
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ (INmune Bio Inc)
Public Technologies 25 Jun 2026
Edit
Enid News & Eagle
23 Jun 2026
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing
Edit
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for ...
Nasdaq Globe Newswire 23 Jun 2026
... Agency (MHRA) for CORDStrom™ (Ebstrocel™) in Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Edit
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB (Form 8-K) (INmune Bio Inc)
Public Technologies 23 Jun 2026
"Definitive MHRA alignment across CMC, non-clinical and clinical strategy is an important regulatory de-risking milestone for Ebstrocel™ and for the broader CORDStrom™ platform," said David Moss, Chief Executive Officer of INmune Bio.
Edit
Update on the PATHWAYS clinical trial (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 19 Jun 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded its scientific dialogue with the trial sponsor on the PATHWAYS clinical trial, and a modified protocol has been agreed as meeting the required regulatory standards.
Edit
Warning on promoting newly licensed prescription-only medicines and unlicensed medicines for weight management (MHRA - Medicines and Healthcare products Regulatory Agency)
Public Technologies 18 Jun 2026
The CAP Code is clear that medicines must have a licence from the MHRA before they are marketed (rule 12.11) and that prescription-only medicines or prescription-only medical treatments cannot be advertised to the public (rule 12.12).
- 1
- 2
- Next page »